ClinicalTrials.Veeva

Menu

Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study

U

University of Indonesia (UI)

Status

Not yet enrolling

Conditions

Nasopharyngeal Carcinoma
Cancer
Mucositis

Treatments

Procedure: Sham Acupuncture
Procedure: Verum Acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT06472024
24-05-0717

Details and patient eligibility

About

The goal of this clinical trial is to learn if acupuncture can play a role in reducing pain and improving the quality of life of post-radiotherapy nasopharyngeal cancer mucositis patients. The main questions it aims to answer are:

  • Do manual acupuncture and medication therapy affect pain intensity as measured by the visual analogue scale (VAS) in patients with oral mucositis compared with sham manual acupuncture and medication?

Participants will receive acupuncture therapy 2 times a week for 3 weeks

Full description

This is a clinical trial study to evaluate the role of acupuncture in pain relief and improving the quality of life of nasopharyngeal cancer patients with post-radiotherapy mucositis. Participants were 30 men/females with mucositis in post-radiotherapy nasopharyngeal cancer aged 19-59 years. They will be divided into 2 groups: (1) verum acupuncture and (2) sham acupuncture. Acupuncture is scheduled 2 times per week for 3 weeks. Research assessment on pain scale and improvement in quality of life

Enrollment

30 estimated patients

Sex

All

Ages

19 to 59 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects who have been proven by anatomical pathology examination to have a diagnosis of Nasopharyngeal Cancer.
  • Subjects with adult Nasopharyngeal Cancer aged 19 years - 59 years.
  • Nasopharyngeal Cancer Patients, who underwent bilateral Head and Neck radiotherapy.
  • Patients diagnosed with mucositis.
  • Willing to participate in the research until completion by signing an informed consent.

Exclusion criteria

  • Nasopharyngeal Cancer patients who have distant metastases (based on the Tumor Node Metastasis (TNM) classification with the presence of metastases (M1)).
  • Subjects who still smoke and consume alcohol to date.
  • Patients have contraindications for manual acupuncture, namely the use of anti-coagulant drugs, the presence of infection or wounds at the puncture site, emergency conditions, and pregnancy.
  • There is a history of allergy to stainless steel materials.
  • Patients with blood clotting disorders; Platelets <50,000/μL, Absolute Neutrophil Count (ANC) <1000/mm3, patients undergoing anticoagulant therapy with International Normalized Ratio (INR) >2.47

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

Verum Acupuncture
Experimental group
Description:
The verum acupuncture group will receive actual acupuncture therapy 2 times per week for 3 weeks
Treatment:
Procedure: Verum Acupuncture
Sham Acupuncture
Sham Comparator group
Description:
The Sham acupuncture group will receive Sham acupuncture therapy 2 times per week for 3 weeks
Treatment:
Procedure: Sham Acupuncture

Trial contacts and locations

0

Loading...

Central trial contact

Imelda Dimara, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems